Waukesha Local News
  Home Hotels Jobs Real Estate Cars Apartments Shopping

Wisconsin

The Marcus Corporation today announced it will participate in Gabelli & Company's Second Annual Digital Cinema and Movie Conference in New York City on Thursday, March 11, 2010 at 10:45 a.m. Eastern Time/9:45 a.m. Central Time. Gregory S. ...
13 hours ago
It's long been known that obesity is linked to increased risk of developing colon cancer, but now researchers at the Mayo Clinic campus in Minnesota have found that obesity is associated with worse outcomes in patients who have already been ...
15 hours ago
Johnson Controls, Inc. , a global multi-industrial leader in energy efficiency and sustainability, today announced that it has completed its previously announced public offering of $500 million aggregate principal amount of senior notes. The senior ...
16 hours ago
The National Association of Minority and Women Owned Law Firms today congratulated 11 major corporations on their successful launch of the Inclusion Initiative and pledged to work hard to ensure that the collaborative effort helps minority and ...
17 hours ago
Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies. Under the agreement, the two companies are promoting the ...
19 hours ago
Brazen Careerist, the leading social network for Generation Y professionals, today launched Social Resumes, the first active, live resume that highlights candidate ideas, thoughts and future plans as much their past experience. The application ...
20 hours ago
Cambridge Major Laboratories, Inc., Avantium Pharma, Xcelience, LLC and Beckloff Associates have formed a consortium of expert client-focused companies to launch Chemistry Playbook, an expedited CMC solutions program designed to accelerate drug ...
20 hours ago
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, I-CLR1404 has ...
20 hours ago